|
Delayed
OTC Markets
19:15:16 05/10/2021 +04
|
5-day change | 1st Jan Change | ||
| 0.1175 USD | -1.26% |
|
+0.34% | +657.96% |
| Market Cap | 2.58M 2.3M 2.14M 1.95M 3.68M 248M 3.72M 25.93M 10.05M 127M 9.7M 9.49M 408M | P/E 2026 * |
-0.34x | P/E 2027 * | -1.67x |
|---|---|---|---|---|---|
| Enterprise Value | 2.58M 2.3M 2.14M 1.95M 3.68M 248M 3.72M 25.93M 10.05M 127M 9.7M 9.49M 408M | EV / Sales 2026 * |
0.07x | EV / Sales 2027 * | 0.06x |
| Free-Float |
98.41% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.26% |
| Manager | Title | Age | Since |
|---|---|---|---|
Steve Slilaty
CEO | Chief Executive Officer | 74 | 15/10/2009 |
Camille Sebaaly
DFI | Director of Finance/CFO | 65 | 15/10/2009 |
Michel Roy
PRN | Corporate Officer/Principal | 58 | 15/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Slilaty
CHM | Chairman | 74 | 15/10/2009 |
Camille Sebaaly
BRD | Director/Board Member | 65 | 11/12/2025 |
Rabi Kiderchah
BRD | Director/Board Member | 53 | 31/10/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.26% | +0.34% | - | - | 2.58M | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.34% | -3.39% | +27.17% | +57.15% | 410.8B | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.52% | +68.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.75M 32.65M 30.48M 27.78M 52.39M 3.53B 52.88M 369M 143M 1.81B 138M 135M 5.8B | 45M 39.98M 37.32M 34.01M 64.15M 4.33B 64.75M 452M 175M 2.21B 169M 165M 7.1B |
| Net income | -4.69M -4.17M -3.89M -3.55M -6.69M -451M -6.75M -47.1M -18.25M -231M -17.62M -17.24M -740M | -1.6M -1.42M -1.33M -1.21M -2.28M -154M -2.3M -16.06M -6.22M -78.63M -6.01M -5.88M -252M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6665USD
Average target price
56.00USD
Spread / Average Target
+8,302.10%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SBFM Stock
- SBFM Stock
Select your edition
All financial news and data tailored to specific country editions
